Does it Pay to Use Pathways?

Segment 11 - Integrating Pathways into the Value-Based Framework
June 30, 2014 – 
Panelists discussed the successes and failures associated with pathway implementation.
Segment 10 - Evidence-Based Medicine in the "Real-World" Healthcare Setting
June 30, 2014 – 
The panelists continued to discuss evidence-based medicine, as well as the incentives there might be to examine emerging and existing therapies or drugs.
Segment 9 - The Use of Expensive or New Immunotherapies in Clinical Pathways
June 30, 2014 – 
In regard to updating pathways and guidelines, Dr Sonnad asked about the opportunity for newer, expensive immunotherapies to be included in a pre-determined pathway.
Segment 8 - Financial Incentives and Penalties
June 30, 2014 – 
Panelists analyzed the concept of penalizing providers who deviate from pathway programs.
Segment 7 - The Complexities of Pathway Development
June 30, 2014 – 
Dr Sonnad inquired how replacing brand drugs with generic equivalents can affect pathway adherence. She also asked panelist to discuss the differences between early-stage and late-stage disease regimens, as well as the degree of flexibility there is in regimen design.
Segment 6 - The Importance of Feedback
June 30, 2014 – 
The panelists further explore feedback and its role in pathway adherence.
Segment 5 - The Use of Tools and Electronic Health Records in Pathway Adherence
June 30, 2014 – 
In this segment, panelists discussed the various tools that are used to measure pathway adherence.
Segment 4 - Payer Panel Pathway Recommendations
June 30, 2014 – 
Dr Sonnad asked panelists about the participants on payer panels who determine the cost-effectiveness of pathways.
Segment 3 - Provider Buy-in and Clinical Pathway Development
June 30, 2014 – 
Dr Yu said that it is crucial for providers' voices to be heard in pathway development.
Segment 2 - Development of Pathway Guidelines
June 30, 2014 – 
The panelists discussed and shared examples of how payers and providers are collaborating to develop pathway guidelines.
Copyright AJMC 2006-2018 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome to the new and improved AJMC.com, the premier managed markets network. Tell us about yourself so that we can serve you better.
Sign Up
×

Sign In

Not a member? Sign up now!